Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
1 15% of men with prostate cancer have a normal PSA. 2  There is no conclusive evidence that detection of early prostate cancer leads to longer survival. 3  The test cannot distinguish between aggressive and slow-growing cancers and may detect tumours that would not otherwise become evident in the patient's lifetime. 15% of men with prostate cancer have a normal PSA. 2  There is no conclusive evidence that detection of early prostate cancer leads to longer survival. 3  The test cannot distinguish between aggressive and slow-growing cancers and may detect tumours that would not otherwise become evident in the patient's lifetime.